Enhanced Recovery After Surgery Program Ups Outcomes

Share this content:
Enhanced Recovery After Surgery Program Ups Outcomes
Enhanced Recovery After Surgery Program Ups Outcomes

FRIDAY, May 12, 2017 (HealthDay News) -- An enhanced recovery after surgery (ERAS) program is associated with improved outcomes for patients undergoing elective colorectal resection and emergency hip fracture repair, according to a study published online May 10 in JAMA Surgery.

Vincent X. Liu, M.D., from Kaiser Permanente in Oakland, Calif., and colleagues examined the outcomes of an ERAS program among 3,768 patients undergoing elective colorectal resection and 5,002 patients undergoing emergency hip fracture repair. A pre-post difference-in-differences study was conducted before and after ERAS implementation in the target populations, compared with contemporaneous surgical comparator groups (5,556 patients undergoing elective gastrointestinal surgery and 1,523 patients undergoing emergency orthopedic surgery).

The researchers observed significantly greater changes in the ERAS target populations in most process metrics after implementation compared with comparator surgical populations, including in ambulation, nutrition, and opioid use. After implementation, among ERAS target populations, hospital length of stay and postoperative complication rates were also significantly lower. The rate ratios for postoperative complications were 0.68 and 0.67 for patients undergoing colorectal resection and for patients with hip fracture, respectively. ERAS implementation correlated with decreased rate of hospital mortality among patients undergoing colorectal resection (0.17); implementation was associated with increased rates of home discharge among patients with hip fracture (1.24) .

"Rapid, large-scale implementation of a multidisciplinary ERAS program is feasible and effective in improving surgical outcomes," the authors write.

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Cost-Effectiveness of PCSK9 Inhibitors Called Into Question

Cost-Effectiveness of PCSK9 Inhibitors Called Into Question

Researchers say price would have to be between $4,000 and $5,000 per year to be cost-effective

Vitamin B6, B12 Supplements May Up Risk of Lung Cancer in Men

Vitamin B6, B12 Supplements May Up Risk of ...

Increased odds only seemed to affect men or male smokers

Tablet Use Encourages Patients to Explore Diabetes Risk

Tablet Use Encourages Patients to Explore Diabetes Risk

Replacing magazines with tablets can help patients learn about diabetes risk, take preventive action

is free, fast, and customized just for you!

Already a member?

Sign In Now »